GSK Shakes Diabetes Drug Row At 3rd Circ.
GlaxoSmithKline on Friday shook a Missouri woman's proposed class action accusing the pharmaceutical company of concealing dangerous side effects of its diabetes drug Avandia when the Third Circuit found the woman...To view the full article, register now.
Already a subscriber? Click here to view full article